News Article,Video
Maple Grove Medical Device Company Shares How They are Surviving During COVID-19
October 5, 2020
CCX Media visited Francis Medical on September 30, 2020, to interview President and CEO Mike Kujak, and get an inside look at how we’re thriving and moving forward during the COVID-19 pandemic, including a $4M investment from world-renown urology company, Coloplast. (2 1/2 min video)
Recent Posts
Francis Medical Announces Northwell Urology Group Performs First Commercial Vanquish® Water Vapor Ablation Procedure in New York
websites2026-08-05T10:33:13-05:00August 5th, 2026|
LAKE SUCCESS, NY, August 5, 2026, - Samir S. Taneja, MD, a urologic oncologist, chairman of the Department of Urology at Northwell Health and professor of urology at the Donald and Barbara Zucker School of Medicine, has performed the first commercial Vanquish® Water Vapor Ablation (Vanquish System) procedure in New York state, marking a significant milestone for patients in the region seeking a minimally invasive prostate care option.
Francis Medical Announces Orange County Urology Associates Becomes First in California to Integrate Vanquish® Water Vapor Ablation into Routine Prostate Care
websites2026-07-09T14:53:10-05:00July 7th, 2026|
Maple Grove, Minn., July 7th, 2026 – Daniel Su, MD, a urologist at Orange County Urology Associates (OCUA), has performed the first commercial Vanquish® Water Vapor Ablation procedures in the state of California, offering patients a new minimally invasive Focal Therapy option as part of the group’s prostate care service. The procedure was completed within a single outpatient visit and did not require a hospital stay. Beyond the clinical milestone, Dr. Su’s experience highlights something equally important: how this technology can be adopted into an existing urology practice.
Francis Medical Announces Publication of VAPOR 2 Pivotal Trial Results in The Journal of Urology
websites2026-07-02T10:26:19-05:00June 30th, 2026|
MAPLE GROVE, Minn., June 30, 2026 – Francis Medical, Inc., a medical device company dedicated to advancing minimally invasive therapies for urological cancers, today announced the publication of the initial report from its VAPOR 2 pivotal clinical study in The Journal of Urology, one of the world’s leading peer-reviewed urology journals.




Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.